BACKGROUND
Noncommunicable diseases (NCDs) kill 41 million people each year, accounting for 71% of all deaths globally. The burden of NCDs is rising faster in developing countries of the Middle East than in other regions. The morbidity and mortality of NCDs are still not well-studied in Yemen.
OBJECTIVE
The aim of this study was to describe the epidemiology of NCDs in Sana’a City, Yemen, for 2017.
METHODS
Raw data of a house-to-house survey that was conducted by the Ministry of Public Health and Population in 2017 were analyzed. Data were collected from household heads who were asked if any household member had one of the following five NCDs: hypertension (HTN), diabetes (DM), bronchial asthma (BA), mental disorders (MD), and epilepsy. Data were entered and analyzed using Epi info 7.2. For calculations of prevalence, 2017 projections from the 2004 census were used.
RESULTS
A total of 241,310 households were surveyed (1,592,646 household members), 59,061 (24.48%) of which included 70,178 members who had at least one NCD. The overall prevalence of NCDs was 4.4%. The disease-specific prevalence was as follows: HTN, 2.3%; DM, 2.2%; BA, 0.4%; MD, 0.27; and epilepsy, 0.19%. The overall NCD prevalence was significantly higher among females than males (5.1% vs 3.8%; odds ratio [OR] 1.35, 95% CI 1.33-1.35), which was also the case for the prevalence of HTN (3.1% vs 1.6%; OR 1.94, 95% CI 1.90-1.98), DM (2.3% vs 2.1%; OR 1.11, 95% CI 1.09-1.13), and BA (0.5% vs 0.3%; OR 1.56, 95% CI 1.49-1.65). In contrast, the prevalence of MD was significantly higher among males than females (0.35% vs 0.16%; OR 2.2, 95% CI 2.06-2.31). The prevalence of NCDs progressively increased with age. Nearly 18% of patients had more than one NCD; 35.2% of the patients with HTN also had DM.
CONCLUSIONS
One-quarter of the surveyed households had at least one member with one or more of the five NCDs and the overall prevalence of NCDs was 4.4%. These data reflect only the tip of the iceberg as the findings are based on self-reported diagnosed cases rather than standardized measures. More attention to NCDs, strengthened health care provision, the ability to obtain high-reliability data, an NCDs stepwise survey, and establishing an NCDs surveillance system are recommended.